Basics and dynamics of neonatal and pediatric pharmacology

Area of Science:

• Pediatric Pharmacology and Developmental Therapeutics
• Translational Medicine and Drug Development

Background:

• Safe and effective pharmacotherapeutics in children requires understanding ontogeny's role in drug disposition and action.
• The pediatric population undergoes continuous maturational changes from infancy through young adulthood, impacting drug responses.

Purpose of the Study:

• To elucidate the fundamental principles of pediatric pharmacology.
• To highlight the critical developmental changes influencing drug efficacy, toxicity, and dosing in children.
• To underscore the importance of developmental dynamics in guiding pediatric drug research.

Main Methods:

• Review of developmental changes in body composition, physiology, and pathophysiology.
• Analysis of ontogeny in drug metabolism, elimination, and target interactions (enzymes, transporters, receptors).
• Consideration of environmental influences and unique pediatric safety hazards.

Main Results:

• Developmental changes significantly alter drug disposition and pharmacological effects throughout childhood and adolescence.
• Immature organ systems exhibit critical developmental windows that can lead to long-term effects.
• Complex, nonlinear interactions between developmental components influence drug responses.

Conclusions:

• Understanding pediatric developmental dynamics is essential for optimizing drug therapy in children.
• This knowledge is crucial for identifying future research priorities in pediatric drug development.
• Developmental pharmacology provides the key to understanding pediatric-specific therapeutic differences.